A recent single-cell study of MCs across cancers divided tumor MCs into two subtypes: protumorigenic MCs, characterized by a low TNF+/VEGFA+ ratio, and antitumorigenic MCs, characterized by a high TNF+/VEGFA+ ratio (9). This evidence concerns the gene VEGFA and neoplasm.